New EV Brand Backed by Five Companies Targets Japans Mini Car Market SEBI Bars Seven Family Members for Social Media Stock Manipulation Alleges 2025 Crore Illegal Gains US Jobless Claims Stay Low Signaling Steady Labor Market Conditions Capgemini Outlines Strategic Plan to Capture AI Growth Opportunities Through 2028 RBI Rate Cut May Signal Policy Framework Shift Nomura Suggests US Productivity Growth Slows in Fourth Quarter as Unit Labor Costs Accelerate JJSF Q1 2026 Earnings EPS Misses Estimates Despite Narrow Surprise Stock Edges Higher RDI Q3 2025 Earnings Significant EPS Miss Highlights Operational Challenges GTIM Q1 2026 Earnings Small Profit Reported Stock Gains ACHC Q1 2026 Earnings Strong EPS Beat Amid Operational Improvements PAPL Q3 2025 Earnings EPS Surprises Positively Despite Revenue Uncertainty Stock Declines Gamblingcom Group GAMB Slides 2 as Traders Eye Key Support at 230 DuPont DD Breakout What the 278 Surge Tells Investors Motorola Solutions Inc MSI Holds Ground at 41087 Amidst RangeBound Trading Republic Power Group Limited RPGL Surges Support Holds Firm at 028 OPKO Health Q1 2026 Earnings Narrowly Beats EPS Estimates Amid Operational Focus TKC Q4 2025 Earnings EPS of 440 Amid Modest Stock Decline FTHM Q4 2025 Earnings EPS Misses Estimates as Losses Widen Stock Edges Higher Radian Group Inc RDN Q1 2026 Earnings EPS Beats Estimates by 285 as Stock Declines Agilent Technologies Q1 2026 Earnings EPS Falls Short of Consensus Shares Edge Higher Arch Capital Group Ltd ACGLO Q1 2026 Earnings Slight EPS Miss Masks Resilient Underwriting Performance Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement for Both Sides SIM Q1 2023 Earnings EPS Misses Estimates by Wide Margin BWFG Q1 2026 Earnings EPS Beats Estimates by 13 Amid Solid Operating Performance DPRO Q1 2026 Earnings Narrowly Misses EPS Estimates No Revenue Reported CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase RKDA Q3 2025 Earnings Arcadia Biosciences Posts Surprise Profit as EPS Smashes Estimates Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline WAFDP Q1 2026 Earnings Earnings Beat Estimates Amid Steady Performance ALZN Q1 2026 Earnings Narrowing Losses Beat Estimates by 70